Metabolic Reprogramming Contributes to Resistance Towards Lenvatinib in Thyroid Cancer

Authors

Institutions

Publication Details

Journal
VideoEndocrinology
Published
2024-12-01
DOI
https://doi.org/10.1089/ve.2024.0020
Citations
1
Primary Topic
Thyroid Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.36
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Metabolic Reprogramming Contributes to Resistance Towards Lenvatinib in Thyroid Cancer

Joanna Kłubo-Gwieździńska, Shilpa Thakur, Stephanie Cardenas, Sonam Kumari et al.
1 citations
VideoEndocrinology
Thyroid Cancer Diagnosis and Treatment
0.36
article

Metabolic Reprogramming Contributes to Resistance Towards Lenvatinib in Thyroid Cancer

Joanna Kłubo-Gwieździńska, Shilpa Thakur, Stephanie Cardenas, Sonam Kumari, Andrew Makarewicz
article en
1 citations

Abstract

No abstract available for this paper.
VideoEndocrinologyVol. 11(4)
National Institute of Diabetes and Digestive and Kidney Diseases (US)
Zero hunger
Openalex Percentile: Top 31%
Thyroid Cancer Diagnosis and Treatment
0.36
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Metabolic Reprogramming Contributes to Resistance Towards Lenvatinib in Thyroid Cancer — Joanna Kłubo-Gwieździńska, Shilpa Thakur, et al. · VideoEndocrinology (2024) | TGRS Research Map | TGRS